UK News Archive

The UK News Archive contains resources intended for journalists only.

2020

October

Media Release / Oct 15, 2020

Novartis’ Mayzent®▼ (siponimod) becomes the first oral treatment recommended by NICE and SMC for adults living with secondary progressive multiple sclerosis (SPMS) with active disease

Read More
Media Release / Oct 12, 2020

Novartis’ Mayzent®▼ (siponimod) receives approval from the Scottish Medicines Consortium as the first recommended treatment in Scotland for patients living with secondary progressive multiple sclerosis (SPMS) with active disease

Read More

September

Media Release / Sep 22, 2020

Tomorrow Transformed

Read More
Media Release / Sep 14, 2020

Novartis presents data at MSVirtual2020 highlighting potential of ofatumumab as an early treatment option for relapsing multiple sclerosis

Read More

August

Story / Aug 25, 2020

Health Hub Accelerator 2020 finalists announced

Read More
Story / Aug 17, 2020

Introducing the heroes of More to uS, who are proving that multiple sclerosis does not define who they are

Read More
Media Release / Aug 07, 2020

Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis

Read More
Story / Aug 04, 2020

COVID-19 pandemic brings fresh focus on mental health

Read More
Story / Aug 03, 2020

Novartis joins forces with leading global health experts to tackle antimicrobial resistance

Read More

July

Story / Jul 29, 2020

Chinmay Bhatt appointed Managing Director UK, Ireland & Nordics for Novartis Pharmaceuticals

Read More

Related Links